These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2689479)

  • 41. The thin layer rapid use epicutaneous test (TRUE-test), a new patch test method with high accuracy.
    Fischer TI; Maibach HI
    Br J Dermatol; 1985 Jan; 112(1):63-8. PubMed ID: 3970835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positive nickel patch tests in infants are of low clinical relevance and rarely reproducible.
    Mortz CG; Kjaer HF; Eller E; Osterballe M; Norberg LA; Høst A; Bindslev-Jensen C; Andersen KE
    Pediatr Allergy Immunol; 2013 Feb; 24(1):84-7. PubMed ID: 23331531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The disturbance of epidermal barrier function in atopy patch test reactions in atopic eczema.
    Gfesser M; Rakoski J; Ring J
    Br J Dermatol; 1996 Oct; 135(4):560-5. PubMed ID: 8915146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative study of IQ-ultra and Finn Chambers test methodologies in detecting 10 common standard allergens that cause allergic contact dermatitis.
    Doumit J; Pratt M
    J Cutan Med Surg; 2012; 16(1):18-22. PubMed ID: 22417991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positive patch test reactions to nickel sulphate are not modified by neighbouring negative fragrance patch tests. A multicenter-study by the German contact dermatitis research group.
    Brasch J; Weichenthal M; Szliska C; Löffler H; Koch P; Grabbe J; Mahler V; Kreilgård B; Hoeck U;
    Acta Derm Venereol; 2006; 86(4):345-7. PubMed ID: 16874422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative study of the density of particles in suspensions for patch testing.
    Vanneste D; Martin P; Lachapelle JM
    Contact Dermatitis; 1980 Apr; 6(3):197-203. PubMed ID: 7389327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reproducibility of atopy patch tests with food and inhalant allergens.
    Ronchetti R; Jesenak M; Barberi S; Ronchetti F; Rennerova Z; Trubacova D; Villa MP
    J Biol Regul Homeost Agents; 2008; 22(1):27-33. PubMed ID: 18394315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring contact sensitization to p-phenylenediamine (PPD) by patch testing with PPD 0.3% in petrolatum.
    Geier J; Ballmer-Weber BK; Dickel H; Frosch PJ; Bircher A; Weisshaar E; Hillen U
    Contact Dermatitis; 2013 Jul; 69(1):26-31. PubMed ID: 23782355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reproducibility of the Finn chamber nickel patch test in two different phases of the ovulatory menstrual cycle.
    Aktan S; Aktan E; Inanir I; Kaleli B; Sanli B
    Dermatology; 1998; 197(3):235-7. PubMed ID: 9812027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishing aluminium contact allergy.
    Siemund I; Zimerson E; Hindsén M; Bruze M
    Contact Dermatitis; 2012 Sep; 67(3):162-70. PubMed ID: 22594839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atopy patch test--reproducibility and elicitation of itch in different application sites.
    Weissenbacher S; Bacon T; Targett D; Behrendt H; Ring J; Darsow U
    Acta Derm Venereol; 2005; 85(2):147-51. PubMed ID: 15823910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sensitization to petrolatum: an unusual cause of false-positive drug patch-tests.
    Ulrich G; Schmutz JL; Trechot P; Commun N; Barbaud A
    Allergy; 2004 Sep; 59(9):1006-9. PubMed ID: 15291911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patch testing with a combination of unrelated allergens: a new strategy.
    McLelland J; Shuster S
    Br J Dermatol; 1996 Oct; 135(4):566-71. PubMed ID: 8915147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concordance and discordance between TRUE Test and Finn Chamber.
    Fernández Vozmediano JM; Hita JC
    Contact Dermatitis; 2000 Mar; 42(3):182-3. PubMed ID: 10727183
    [No Abstract]   [Full Text] [Related]  

  • 55. A new occlusive patch test system comparable to IQ and Finn chambers.
    Sajun Merchant SZ; Vaidya AD; Salvi A; Joshi RS; Mohile RB
    Indian J Dermatol Venereol Leprol; 2014; 80(4):291-5. PubMed ID: 25035351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concordance of patch test results with four new TRUE test allergens compared with the same allergens from Chemotechnique.
    Andersen KE; Paulsen E
    Contact Dermatitis; 2009 Jan; 60(1):59. PubMed ID: 19125728
    [No Abstract]   [Full Text] [Related]  

  • 57. Stability of fragrance patch test preparations applied in test chambers.
    Mowitz M; Zimerson E; Svedman C; Bruze M
    Br J Dermatol; 2012 Oct; 167(4):822-7. PubMed ID: 22803625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of reactivity to allergens using the TRUE Test and IQ chamber system.
    Lazarov A; David M; Abraham D; Trattner A
    Contact Dermatitis; 2007 Mar; 56(3):140-5. PubMed ID: 17295688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skin absorption from patch test systems.
    Kim HO; Wester RC; McMaster JA; Bucks DA; Maibach HI
    Contact Dermatitis; 1987 Sep; 17(3):178-80. PubMed ID: 3677660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recommendation to include fragrance mix 2 and hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral) in the European baseline patch test series.
    Bruze M; Andersen KE; Goossens A; ;
    Contact Dermatitis; 2008 Mar; 58(3):129-33. PubMed ID: 18279149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.